中西医结合个体化治疗肝癌162例探讨  

Approaching on 162 cases with hepatoma individualized treated by integrated traditional chinese and western medicine

作　　者：高华[1] 罗泽民[1] 黄晓平[1] 

机构地区：[1]广东省农垦中心医院,广东湛江524002

出　　处：《中外医学研究》2010年第29期69-70,共2页CHINESE AND FOREIGN MEDICAL RESEARCH

摘　　要：目的 探索中西医结合个体化治疗肝癌的方法和效果.方法 根据现有治疗肝癌手段的特点和患者当时的具体情况,用放射导管介入治疗、放射治疗、放射性核素、抗癌中药等＂攻邪＂,用中医药辨证施治汤剂、药膳、免疫生物治疗等＂扶正＂.结果 1/2、1、2、3、5年生存率分别为89.24%、66.21%、 37.40%、29.09%、23.94%.结论 以调整机体功能状态为主个体化综合治疗原发性肝癌有效.Objective To explore methods and effectiveness of combination of TCM with western medie, ine individualized treatment. Methods According to c device of treatment for hepatoma and specifi matter of the patients,using radiate catheter interventional therapy, radiation therapy, radioactive nuclide, anticancer Chinese medicine ＂to attack pathogene＂ Chinese medicine to determine the treatment based on differentiation of symptoms and signs medicinal, medicicined diet, immune biotherapy to strengthening body resistance. Results Survival rate of 1/2,1,2,3,5 years is 89.24% ,66.21% ,37.40% ,29.09% ,23.94%. Conclusion It is utility to treat primary hepatic carcinoma by individualized combined therapy primary with adjusting the organism functional status.

关 键 词：原发性肝癌 机体功能状态 综合治疗 个体化 

分 类 号：R735.7[医药卫生—肿瘤]